Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruce Bode

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 15, 2018
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc AnalysisKeith Bowering, Helena W Rodbard, David Russell-Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2015
Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 DiabetesSharad Purohit, Ashok Sharma, Diane Hopkins, et al.
JAMA|August 19, 2015
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical TrialMelanie J Davies, Richard Bergenstal, Bruce Bode, et al.
Diabetes Care|August 14, 2009
Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes, Bruce Bode, Roy W Beck, et al.
Diabetes Technology & Therapeutics|February 22, 2017
Evaluation of a Predictive Low-Glucose Management System In-ClinicBruce A Buckingham, Timothy S Bailey, Mark Christiansen, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 12, 2021
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes MellitusGeorge Grunberger, Jennifer Sherr, Myriam Allende, et al.
Frontiers in Endocrinology|February 10, 2016
IGF-Binding Proteins in Type-1 Diabetes Are More Severely Altered in the Presence of ComplicationsAshok Sharma, Sharad Purohit, Shruti Sharma, et al.
Plos One|May 3, 2011
Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complicationsRuili Guan, Sharad Purohit, Hongjie Wang, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|February 8, 2021
Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 DiabetesSanjeev N Mehta, Liane J Tinsley, Davida Kruger, et al.
Molecular & Cellular Proteomics : MCP|September 9, 2011
Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassaysWenbo Zhi, Ashok Sharma, Sharad Purohit, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|December 15, 2018
Investigating the Association Between Baseline Characteristics (HbA1c and Body Mass Index) and Clinical Outcomes of Fast-Acting Insulin Aspart in People with Diabetes: A Post Hoc AnalysisKeith Bowering, Helena W Rodbard, David Russell-Jones, et al.
The Journal of Clinical Endocrinology and Metabolism|July 10, 2015
Large-Scale Discovery and Validation Studies Demonstrate Significant Reductions in Circulating Levels of IL8, IL-1Ra, MCP-1, and MIP-1β in Patients With Type 1 DiabetesSharad Purohit, Ashok Sharma, Diane Hopkins, et al.
JAMA|August 19, 2015
Efficacy of Liraglutide for Weight Loss Among Patients With Type 2 Diabetes: The SCALE Diabetes Randomized Clinical TrialMelanie J Davies, Richard Bergenstal, Bruce Bode, et al.
Diabetes Care|August 14, 2009
Sustained benefit of continuous glucose monitoring on A1C, glucose profiles, and hypoglycemia in adults with type 1 diabetes, Bruce Bode, Roy W Beck, et al.
Diabetes Technology & Therapeutics|February 22, 2017
Evaluation of a Predictive Low-Glucose Management System In-ClinicBruce A Buckingham, Timothy S Bailey, Mark Christiansen, et al.
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|June 12, 2021
American Association of Clinical Endocrinology Clinical Practice Guideline: The Use of Advanced Technology in the Management of Persons With Diabetes MellitusGeorge Grunberger, Jennifer Sherr, Myriam Allende, et al.
Frontiers in Endocrinology|February 10, 2016
IGF-Binding Proteins in Type-1 Diabetes Are More Severely Altered in the Presence of ComplicationsAshok Sharma, Sharad Purohit, Shruti Sharma, et al.
Plos One|May 3, 2011
Chemokine (C-C motif) ligand 2 (CCL2) in sera of patients with type 1 diabetes and diabetic complicationsRuili Guan, Sharad Purohit, Hongjie Wang, et al.
Clinical Diabetes : a Publication of the American Diabetes Association|February 8, 2021
Improved Glycemic Control Following Transition to Tubeless Insulin Pump Therapy in Adults With Type 1 DiabetesSanjeev N Mehta, Liane J Tinsley, Davida Kruger, et al.
Molecular & Cellular Proteomics : MCP|September 9, 2011
Discovery and validation of serum protein changes in type 1 diabetes patients using high throughput two dimensional liquid chromatography-mass spectrometry and immunoassaysWenbo Zhi, Ashok Sharma, Sharad Purohit, et al.
Pageof 7